Clinical and electrophysiological evaluation of the effect of adjuvant peripheral magnetic stimulation in the treatment of post-stroke ankle flexor spasticity-randomized controlled study

Ankara University0 sites80 target enrollmentFebruary 14, 2022

Overview

No summary available.

Registry

who.int

Start Date

February 14, 2022

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

•1\) Being diagnosed with stroke according to the definition of the World Health Organization (1989\)
•2\) Being over 18 years old
•3\) Having a stroke confirmed by Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)
•4\) Patients with spasticity between 1 and 3 according to the Modified Ashworth Scale (MAS) in the lower extremity plantar flexor muscles
•5\) Wellness of the patient's general condition after stroke

•1\) Patients treated with botulinum toxin, phenol, alcohol injection for spasticity in the last 6 months
•2\) Patients who have previously undergone antispastic surgery to the treatment area
•3\) Patients with a change in oral antispastic drug use in the last 6 months
•4\) Patients with fixed ankle contracture
•5\) Patients with signs of acute inflammation in the treatment area
•6\) Patients with bleeding diathesis
•7\) Patients with implanted devices (cardiac pacemaker, cochlear implant, drug pumps)
•8\) Patients with vascular problems such as deep vein thrombosis, phlebitis, varicose veins, arterial disease
•9\) Patients with a history of cancer in the treatment area
•10\) Pregnancy